Department of Ophthalmology and Optometry of the Medical University Vienna
Vienna, State of Vienna, 1090, Austria
NCT Number: NCT01936701
Age-related cataract is the main cause of impaired vision in the elderly population worldwide.
The only treatment that can restore functional visual ability is cataract surgery where the opacified crystalline lens is removed by phacoemulsification and an artificial intraocular lens is implanted into the remaining capsular bag. Cataract operations are generally very successful, with a low risk of serious complications.
The most common reason for impaired vision after uneventful cataract surgery in otherwise healthy eyes is the development of posterior capsule opacification (PCO). PCO is a physiological change (thickening, opacification and clouding) of the capsular bag expected after cataract surgery, because the lens epithelial cells (LECs) undergo hyperplasia and cellular migration. PCO is treated with Nd:YAG capsulotomy, a quick outpatient procedure that uses a laser to open a central hole in the posterior capsular bag.
Modifications in IOL design and material lead to a decrease in the incidence of PCO.
During the past two decades, refinements in surgical technique were made resulting in today's small incision phacoemulsification surgery. Nowadays a multitude of microincision IOLs are available, many of them similar but of course with some differences in regard to the chemical composition of the acrylic material and the IOL design.
The purpose of this study is to compare the development of posterior capsule opacification (PCO) and the frequency of treatment between two different microincision IOLs over a period of 2 years.
Looking for future studies?
Notify Me40 year–90 year
All sexes
Interventional
Not applicable
Vienna, State of Vienna, 1090, Austria
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
same-day bilateral cataract surgery with implantation of intraocular lens
Time frame: 2 xears
subjective and objective PCO scoring
Time frame: 2 years
Time frame: 2 years
Medical University of Vienna
Other
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT02975895
Cataract, Eye Diseases
Mölndal, Sweden
View Trial DetailsNCT01786356
Capsule Opacification, Cataract
Vienna, State of Vienna, Austria
View Trial DetailsNCT01734343
Capsule Opacification, Cataract
Vienna, State of Vienna, Austria
View Trial DetailsNCT06060041
Cataract, Eye Diseases
Dothan, Alabama, United States
View Trial Details